Latest News | Biocon Gets USFDA Nod for Generic Product
Get latest articles and stories on Latest News at LatestLY. Biotechnology major Biocon on Thursday said its unit has received approval from the US health regulator to market a generic product.
New Delhi, Dec 2 (PTI) Biotechnology major Biocon on Thursday said its unit has received approval from the US health regulator to market a generic product.
Biocon Pharma, a subsidiary of the company, has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Mycophenolic Acid, the company said in a regulatory filing.
The product is indicated for the prophylaxis of organ rejection in adult patients receiving a kidney transplant and is available in 180mg and 360mg strengths.
This approval further adds to Biocon's portfolio of vertically integrated complex drug products, the company noted. HRS hrs
Also Read | Redmi Note 10S 8GB RAM + 128GB Variant Launched in India.
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)